Product image of Naprosyn (Naproxen) supplied by GNH India

Naprosyn

Active Ingredient:
Naproxen
Origin:
EU

Naprosyn (Naproxen)

Naproxen, the active ingredient in Naprosyn, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for external use. It treats pain, inflammation and musculoskeletal disorders in adult patients who require localized relief.
GNH India supplies Naprosyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Recordati Industria Chimica E Farmaceutica S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naprosyn (naproxen) is applied topically to manage conditions that involve pain and inflammation of the musculoskeletal system.

  • Osteoarthritis: reduces joint pain and swelling in affected joints.
  • Rheumatoid arthritis: alleviates localized inflammatory discomfort.
  • Acute muscle strain: eases pain and limits swelling after injury.
  • Tendinitis and bursitis: provides targeted relief of tendon and bursa inflammation.

How It Works

  • Naproxen inhibits cyclooxygenase enzymes COX‑1 and COX‑2 in a non‑selective manner, decreasing the conversion of arachidonic acid to prostaglandins. Reduced prostaglandin synthesis limits inflammation, pain signalling, and fever responses at the site of application, providing localized therapeutic effects without systemic activation of the enzyme pathways.

Side Effects

Topical naproxen may cause local and systemic adverse reactions.

Common Side Effects

  • Skin irritation: redness, itching or burning at the application site.
  • Dryness: localized dryness or peeling of the skin.
  • Mild headache: occasional tension‑type headache.
  • Gastrointestinal discomfort: mild nausea or dyspepsia.
  • Pruritus: itching without rash.
  • Localized erythema: mild redness.

Serious or Rare Side Effects

  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Cardiovascular events: increased risk of heart attack or stroke.
  • Gastrointestinal ulceration or bleeding.
  • Renal impairment: reduced kidney function.
  • Hepatotoxicity: elevated liver enzymes.
  • Anaphylaxis: life‑threatening allergic reaction.

Precautions & Warnings

Use Naprosyn with awareness of specific safety considerations.

  • Contraindication: avoid in patients with known hypersensitivity to naproxen or other NSAIDs.
  • Cardiovascular risk: limit use in individuals with a history of heart disease or stroke.
  • Renal caution: monitor kidney function in patients with pre‑existing renal impairment.
  • Gastrointestinal caution: use cautiously in those with ulcer disease or gastrointestinal bleeding history.
  • Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding.
  • Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Naproxen may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
  • Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
  • Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in antihypertensive effect.
  • Diuretics: may diminish diuretic efficacy and affect renal function.
  • Lithium: naproxen can raise lithium serum concentrations.

Frequently Asked Questions

Naprosyn, containing naproxen, is applied topically to relieve pain and reduce inflammation associated with osteoarthritis, rheumatoid arthritis, acute muscle strains, tendinitis and bursitis. The localized formulation targets the affected area, providing symptom control without the need for systemic medication.

When applied topically, naproxen penetrates the skin and inhibits the cyclooxygenase enzymes COX‑1 and COX‑2 in the underlying tissues. This blocks prostaglandin production, which is a key mediator of pain, swelling and fever, thereby delivering localized anti‑inflammatory and analgesic effects.

The specific amount of Naprosyn to apply, frequency of use, and duration of therapy are determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms and treatment response. Patients should follow the prescriber’s instructions exactly.

Safety of topical naproxen in pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Naprosyn.

To request Naprosyn, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naprosyn delivers naproxen, a non‑selective COX inhibitor, whereas many alternative gels contain ibuprofen or diclofenac. Naproxen’s longer half‑life may allow less frequent application, but individual response varies. Choice of product should consider efficacy, tolerability, and the prescriber’s clinical judgment.

Store Naprosyn at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed when not in use.

Clean and dry the affected skin area before use. Apply a thin layer of the gel or cream to the site and gently massage until fully absorbed. Follow the frequency and duration prescribed by the healthcare professional, and avoid covering the area with occlusive dressings unless directed.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome, cardiovascular events like heart attack or stroke, gastrointestinal bleeding or ulceration, and renal or hepatic impairment. Patients should seek immediate medical attention if they notice signs of these conditions.

Individuals with known hypersensitivity to naproxen or any NSAID, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic disease should avoid using Naprosyn. A healthcare professional should evaluate suitability before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naproxen

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT